Fundamental Analysis of ENDO INTERNATIONAL PLC(NASDAQ:ENDP) stock

Fundamental Rating

ENDP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 198 industry peers in the Pharmaceuticals industry. ENDP has a bad profitability rating. Also its financial health evaluation is rather negative. ENDP is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ENDP was profitable.

ENDP had negative earnings in 4 of the past 5 years.

ENDP had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	-40.81%
ROE	N/A
ROIC	8.07%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

		Industry Rank	Sector Rank
OM	19.02%
PM (TTM)	-93.31%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ENDP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.

Compared to 1 year ago, ENDP has more shares outstanding

The debt/assets ratio for ENDP is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -3.02, we must say that ENDP is in the distress zone and has some risk of bankruptcy.

A Debt/Equity ratio of -2.52 indicates that ENDP is not too dependend on debt financing.

		Industry Rank	Sector Rank
Debt/Equity	-2.52
Debt/FCF	N/A
Altman-Z	-3.02

ROIC/WACC1.22

WACC6.62%

2.3 Liquidity

A Current Ratio of 1.86 indicates that ENDP should not have too much problems paying its short term obligations.

A Quick Ratio of 1.62 indicates that ENDP should not have too much problems paying its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	1.86
Quick Ratio	1.62

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ENDP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.08%.

ENDP shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.54% yearly.

Looking at the last year, ENDP shows a decrease in Revenue. The Revenue has decreased by -1.56% in the last year.

ENDP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.68% yearly.

EPS 1Y (TTM)-12.08%

EPS 3Y1.48%

EPS 5Y-8.54%

EPS growth Q2Q-95.38%

Revenue 1Y (TTM)-1.56%

Revenue growth 3Y0.52%

Revenue growth 5Y-5.68%

Revenue growth Q2Q-20.27%

3.2 Future

Based on estimates for the next years, ENDP will show a very negative growth in Earnings Per Share. The EPS will decrease by -34.53% on average per year.

Based on estimates for the next years, ENDP will show a decrease in Revenue. The Revenue will decrease by -8.13% on average per year.

EPS Next Y-57.56%

EPS Next 2Y-45.48%

EPS Next 3Y-38.91%

EPS Next 5Y-34.53%

Revenue Next Year-18.43%

Revenue Next 2Y-12.85%

Revenue Next 3Y-9.64%

Revenue Next 5Y-8.13%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 0.13, the valuation of ENDP can be described as very cheap.

The average S&P500 Price/Earnings ratio is at 24.92. ENDP is valued rather cheaply when compared to this.

ENDP is valuated cheaply with a Price/Forward Earnings ratio of 0.33.

The average S&P500 Price/Forward Earnings ratio is at 21.49. ENDP is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	0.13
Fwd PE	0.33

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	7.29

4.3 Compensation for Growth

ENDP's earnings are expected to decrease with -38.91% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-45.48%

EPS Next 3Y-38.91%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ENDP does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ENDO INTERNATIONAL PLC

NASDAQ:ENDP (8/25/2022, 9:28:44 PM)

After market: 0.26 -0.03 (-11.14%)

0.2926

-0.02 (-5%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap68.80M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	0.13
Fwd PE	0.33
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-40.81%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	19.02%
PM (TTM)	-93.31%
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.44

Health

		Industry Rank	Sector Rank
Debt/Equity	-2.52
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.86
Quick Ratio	1.62
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-12.08%

EPS 3Y1.48%

EPS 5Y

EPS growth Q2Q

EPS Next Y-57.56%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-1.56%

Revenue growth 3Y0.52%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

ENDO INTERNATIONAL PLC (ENDP)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens